Jazz Pharmaceuticals PLC (JAZZ)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	3,435,430	3,245,750	3,009,860	2,784,650	2,606,140	2,571,500	2,590,830	2,500,860	2,611,330	2,628,230	2,953,960	3,166,900	2,839,570	2,555,570	2,302,350	1,517,640	1,630,270	1,520,560	1,370,070	1,305,620
Total current liabilities	US$ in thousands	1,536,690	1,573,330	945,265	908,902	933,193	812,954	705,442	737,409	809,303	735,053	880,588	752,093	653,745	642,133	409,960	396,123	364,490	390,439	369,493	413,999
Current ratio		2.24	2.06	3.18	3.06	2.79	3.16	3.67	3.39	3.23	3.58	3.35	4.21	4.34	3.98	5.62	3.83	4.47	3.89	3.71	3.15

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,435,430K ÷ $1,536,690K
= 2.24

The current ratio of Jazz Pharmaceuticals plc has exhibited fluctuations over the past eight quarters. The ratio was highest in the second quarter of 2023 at 3.18 and lowest in the third quarter of 2023 at 2.06. Overall, the current ratio has been above 2 in all periods, indicating that the company has a comfortable level of current assets to cover its current liabilities. However, the trend shows some variability, suggesting potential shifts in the company's liquidity position. It is important for stakeholders to monitor these fluctuations to assess the company's ability to meet its short-term obligations.